J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India
· Delayed Price · Currency is INR 1,606.85
-23.20 (-1.42%)
Feb 21, 2025, 3:30 PM IST
NSE:JBCHEPHARM Revenue
J. B. Chemicals & Pharmaceuticals had revenue of 9.63B INR in the quarter ending December 31, 2024, with 14.09% growth. This brings the company's revenue in the last twelve months to 38.30B, up 13.16% year-over-year. In the fiscal year ending March 31, 2024, J. B. Chemicals & Pharmaceuticals had annual revenue of 34.84B with 10.63% growth.
Revenue (ttm)
38.30B
Revenue Growth
+13.16%
P/S Ratio
n/a
Revenue / Employee
7.21M
Employees
5,311
Market Cap
249.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
| Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
| Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
| Mar 31, 2021 | 20.43B | 2.68B | 15.09% |
| Mar 31, 2020 | 17.75B | 1.32B | 8.00% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
J. B. Chemicals & Pharmaceuticals News
- 3 months ago - KKR Is Said to Consider Selling $750 Million Stake in JB Pharma - BNN Bloomberg
- 4 months ago - Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside - Business Upturn
- 4 months ago - Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83% - Business Upturn
- 5 months ago - Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance - Business Upturn
- 5 months ago - JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28% - Business Upturn